Understanding the gut microbiota and sarcopenia: a systematic review

Chaoran Liu, Wing‐Hoi Cheung, Jie Li, Simon Kwoon‐Ho Chow, Jun Yu, Sunny H. Wong, Margaret Ip, Joseph J.�y. Sung, Ronald Man Yeung WongJournal of Cachexia Sarcopenia and Muscle 2021 · DOI

Abstract

Altering the gut microbiota through bacteria depletion, faecal transplantation, and various supplements was shown to directly affect muscle phenotypes. Probiotics, prebiotics, SCFAs, and bacterial products are potential novel therapies to enhance muscle mass and physical performance. Lactobacillus and Bifidobacterium strains restored age-related muscle loss. Potential mechanisms of microbiome modulating muscle mainly include protein, energy, lipid, and glucose metabolism, inflammation level, neuromuscular junction, and mitochondrial function. The role of the gut microbiota in the development of muscle loss during aging is a crucial area that requires further studies for translation to patients.
BibTeX
@article{liu2021understanding,
  author = {Chaoran Liu and Wing‐Hoi Cheung and Jie Li and Simon Kwoon‐Ho Chow and Jun Yu and Sunny H. Wong and Margaret Ip and Joseph J.�Y. Sung and Ronald Man Yeung Wong},
  title = {{Understanding the gut microbiota and sarcopenia: a systematic review}},
  journal = {Journal of Cachexia Sarcopenia and Muscle},
  year = {2021},
  doi = {10.1002/jcsm.12784},
}

Loading related content...

Figure